By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Castle Creek Pharmaceuticals 

90 Washington Valley Road

Bedminster  New Jersey  07921  U.S.A.
Phone: 973-719-8943 Fax: n/a


SEARCH JOBS

Castle Creek Pharma is a fully integrated pharmaceutical company founded by an experienced team of pharmaceutical entrepreneurs. We have rapidly assembled a robust and diversified late stage pipeline of innovative and high potential products in the specialty dermatology and ENT space and in other areas of high medical need. We pride ourselves on the strong relationships that we have forged with our key partners in industry, academia and patient based organizations, which have been instrumental in helping us to advance our products rapidly in development.

YEAR FOUNDED:

2015

LEADERSHIP:

Founder and CEO: Michael Derby

Founder: Jeffrey Aronin

CSO: Greg Licholai

CCO: John Koconis

JOBS:

Please click here for Castle Creek Pharma job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email: contact@castlecreekpharma.com
Ownership: Private

Web Site: Castle Creek Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
Castle Creek Pharma Announces First Patient Enrolled In DELIVERS Study Of Diacerein 1% Ointment For Epidermolysis Bullosa Simplex 6/5/2017 8:04:43 AM
Castle Creek Pharma Announces Presentation Of Phase II Clinical Data For Diacerein 1% Ointment In Treatment Of Epidermolysis Bullosa Simplex 3/6/2017 9:17:43 AM
Castle Creek Pharma Announces License Of Exclusive U.S. Rights For Arlevert From Hennig Arzneimittel Gmbh 12/13/2016 8:19:07 AM
Castle Creek Pharma Continues To Build Executive Team As Company Secures Funding, Positive Phase 2 Results 11/2/2016 10:55:50 AM
Castle Creek Pharma Continues To Build Executive Team As Company Secures Funding, Positive Phase 2 Results 11/1/2016 11:46:19 AM
Castle Creek Pharma Continues To Build Executive Team As Company Secures Funding, Positive Phase II Results 11/1/2016 11:44:08 AM
Castle Creek Pharma Raises $48 Million In Funding From Fidelity Investments 10/4/2016 11:26:55 AM
Castle Creek Pharma Announces Late-Breaking Results At EADV Of Phase 2 Topical Diacerein 1% Data In Patients With Epidermolysis Bullosa Simplex (EBS) 10/3/2016 10:47:14 AM
//-->